Inspra Related Clinical Trials
Eplerenone for the Treatment of Central Serous Chorioretinopathy [Active, not recruiting]
Eplerenone for Central Serous Chorioretinopathy [Recruiting]
The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium [Recruiting]
Eplerenone and Extracellular Adenosine Formation [Completed]
A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives [Completed]
EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia [Completed]
Eplerenone, ACE Inhibition and Albuminuria [Completed]
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction [Completed]
Eplerenone in the Management of Abdominal Aortic Aneurysms [Not yet recruiting]
Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity [Completed]
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease [Recruiting]
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis (MIRACULOUS) Trial [Not yet recruiting]
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer [Recruiting]
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy [Not yet recruiting]
The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure [Completed]
Eplerenone in HIV Associated Abdominal Fat Accumulation [Recruiting]
Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT) [Not yet recruiting]
PHOspholamban RElated CArdiomyopathy STudy - Intervention [Enrolling by invitation]
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions [Completed]
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions [Completed]
Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes [Recruiting]
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population [Recruiting]
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure [Recruiting]
EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion [Terminated]
CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone [Recruiting]
EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety [Recruiting]
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy [Recruiting]
Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients [Withdrawn]
Patient's Management Receiving Eplerenone Therapy [Completed]
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension [Recruiting]
Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack [Completed]
The Long-Term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years [Completed]
A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. [Completed]
CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression [Withdrawn]
Eplerenone in Hemodialysis Trial [Active, not recruiting]
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy [Recruiting]
The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension) [Recruiting]
Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects [Recruiting]
Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics [Completed]
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure [Completed]
A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension [Terminated]
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome [Completed]
Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension [Completed]
Does Aldosterone Cause Hypertension by a Non-Renal Mechanism? [Not yet recruiting]
Eplerenone in Systemic Right Ventricle [Completed]
Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone [Completed]
Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy [Recruiting]
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension [Terminated]
Aldosterone Antagonism in Diastolic Heart Failure [Completed]
Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT [Completed]
Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862 [Completed]
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone [Completed]
Aldosterone Antagonism and Microvascular Function [Recruiting]
Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan) [Completed]
The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria [Completed]
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity [Recruiting]
Treatment of Supine Hypertension in Autonomic Failure [Recruiting]
Diurnal Variation of Plasminogen Activator Inhibitor-1 [Active, not recruiting]
Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy [Active, not recruiting]
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism [Not yet recruiting]
PREDICT: Eplerenone in Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure [Completed]
Detection of Diffuse Scar in Patients With Diabetes [Not yet recruiting]
LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension [Terminated]
Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives. [Recruiting]
A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic [Completed]
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension [Completed]
Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance [Completed]
Hypoglycemia and the Mineralocorticoid Receptor [Recruiting]
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects [Active, not recruiting]
Hypoglycemia and Autonomic Nervous System Function [Recruiting]
Effect of Eplerenone on Endothelial Function in Patients With Stable Coronary Heart Disease [Completed]
A Study of LY2623091 in Male and Females With Chronic Kidney Disease [Completed]
Inhibition of Aldosterone in Patients With Chronic Renal Disease [Completed]
Aldosterone and Vascular Disease in Diabetes Mellitus [Completed]
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function [Terminated]
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone [Completed]
Evaluating the Link Between Thiazide Medications, the Nervous System, and Diabetes in Individuals With High Blood Pressure [Completed]
Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas [Recruiting]
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size [Recruiting]
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]
Biomarkers and Therapeutic Modelisation in Heart Failure [Recruiting]
RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough [Recruiting]
Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response [Recruiting]
|
